181 related articles for article (PubMed ID: 8685080)
1. Pharmacological treatment of central nervous system trauma.
Faden AI
Pharmacol Toxicol; 1996 Jan; 78(1):12-7. PubMed ID: 8685080
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological strategies in CNS trauma.
Faden AI; Salzman S
Trends Pharmacol Sci; 1992 Jan; 13(1):29-35. PubMed ID: 1311880
[TBL] [Abstract][Full Text] [Related]
3. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury.
Faden AI
Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771
[TBL] [Abstract][Full Text] [Related]
4. Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review.
McIntosh TK
J Neurotrauma; 1993; 10(3):215-61. PubMed ID: 8258838
[TBL] [Abstract][Full Text] [Related]
5. Opiate antagonists and thyrotropin-releasing hormone. II. Potential role in the treatment of central nervous system injury.
Faden AI
JAMA; 1984 Sep; 252(11):1452-4. PubMed ID: 6433052
[No Abstract] [Full Text] [Related]
6. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies.
Juurlink BH; Paterson PG
J Spinal Cord Med; 1998 Oct; 21(4):309-34. PubMed ID: 10096045
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin-releasing hormone and central nervous system trauma.
Faden AI; Vink R; McIntosh TK
Ann N Y Acad Sci; 1989; 553():380-4. PubMed ID: 2497681
[TBL] [Abstract][Full Text] [Related]
8. Acute spinal cord injury, part II: contemporary pharmacotherapy.
Dumont RJ; Verma S; Okonkwo DO; Hurlbert RJ; Boulos PT; Ellegala DB; Dumont AS
Clin Neuropharmacol; 2001; 24(5):265-79. PubMed ID: 11586111
[TBL] [Abstract][Full Text] [Related]
9. Experimental neurobiology of central nervous system trauma.
Faden AI
Crit Rev Neurobiol; 1993; 7(3-4):175-86. PubMed ID: 8221911
[TBL] [Abstract][Full Text] [Related]
10. [The physiopathology of acute spinal cord injury and a hope for a successful treatment].
Harat M; Radek A; Kochanowski J
Neurol Neurochir Pol; 1996; 30(1):123-35. PubMed ID: 8657340
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury.
Amar AP; Levy ML
Neurosurgery; 1999 May; 44(5):1027-39; discussion 1039-40. PubMed ID: 10232536
[TBL] [Abstract][Full Text] [Related]
12. Involvement of lipid peroxidation in CNS injury.
Braughler JM; Hall ED
J Neurotrauma; 1992 Mar; 9 Suppl 1():S1-7. PubMed ID: 1588600
[TBL] [Abstract][Full Text] [Related]
13. TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies.
Faden AI
Brain Res; 1989 May; 486(2):228-35. PubMed ID: 2499400
[TBL] [Abstract][Full Text] [Related]
14. Free radicals in CNS injury.
Hall ED; Braughler JM
Res Publ Assoc Res Nerv Ment Dis; 1993; 71():81-105. PubMed ID: 8380240
[TBL] [Abstract][Full Text] [Related]
15. [Neuronal protection in neurologic diseases?].
Bähr M; Eschweiler GW; Dichgans J
Nervenarzt; 1994 Jun; 65(6):355-60. PubMed ID: 8072588
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches for the prevention of secondary brain injury.
McIntosh TK; Smith DH; Garde E
Eur J Anaesthesiol; 1996 May; 13(3):291-309. PubMed ID: 8737120
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic strategies in the treatment of experimental spinal cord injury.
Nockels R; Young W
J Neurotrauma; 1992 Mar; 9 Suppl 1():S211-7. PubMed ID: 1588610
[TBL] [Abstract][Full Text] [Related]
18. Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury.
Gentile NT; McIntosh TK
Ann Emerg Med; 1993 Jun; 22(6):1028-34. PubMed ID: 8099259
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?
Sullivan PG; Rabchevsky AG; Waldmeier PC; Springer JE
J Neurosci Res; 2005 Jan 1-15; 79(1-2):231-9. PubMed ID: 15573402
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional drug treatment in neurotrauma.
Stoica B; Byrnes K; Faden AI
Neurotherapeutics; 2009 Jan; 6(1):14-27. PubMed ID: 19110196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
